{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:20:09Z","timestamp":1746591609309,"version":"3.40.5"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Patients with hypertrophic cardiomyopathy (HCM) usually have abnormal electrocardiograms consistent with left ventricular hypertrophy (LVH). The goal of this study was to evaluate the prevalence of abnormal ECG findings (LVH, T wave inversion, left bundle branch block, and left atrial enlargement) in participants with suspected HCM detected during screening echocardiography.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>The Anthony Bates Foundation has been performing screening echocardiography across the United States for the prevention of sudden death since 2001. A total of 682 subjects between the ages of 8 and 71 underwent echocardiographic screening together with ECG documentation. We evaluated the prevalence of abnormal ECG in participants with suspected HCM defined as any left ventricular wall thickness \u226515\u2009mm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The prevalence of LVH and T wave inversion were higher in HCM subjects as expected [HCM occurred in 23.5% (4\/17) vs. 5.6% (37\/665), <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002, T wave inversion occurred in 17.6% (3\/17) vs. 4.1% (27\/664), <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.007]. However, despite adding these 2 common ECG abnormalities in this population, the presence of detected abnormal ECG remained less than 25% (23.5% of HCM subjects had LVH or T wave inversion on ECG vs. 8.7% of control, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.036). Left bundle branch block or abnormal left atrium on ECG were not found in any participants with suspected HCM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The prevalence of abnormal ECG in the participants with suspected HCM detected during screening echocardiography is less than 25%. This suggests that ECG alone is not a sensitive marker for the detection of HCM.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/hpc.0000000000000346","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T18:06:39Z","timestamp":1708538799000},"page":"20-25","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Majority of Participants With Suspected Hypertrophic Cardiomyopathy Documented During Screening Echocardiography Have a Normal Electrocardiogram"],"prefix":"10.1097","volume":"23","author":[{"given":"Mohammad Reza","family":"Movahed","sequence":"first","affiliation":[{"name":"From the Department of Medicine, University of Arizona Sarver Heart Center, Tucson"},{"name":"Department of Medicine, University of Arizona, College of Medicine, Phoenix"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyvan","family":"Irannejad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jamaica Hospital Medical Center, Queens, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Bates","sequence":"additional","affiliation":[{"name":"Anthony Bates Foundation, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"R1-20250506","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.115.020254","article-title":"Sudden cardiac death in the young.","volume":"133","author":"Ackerman","year":"2016","journal-title":"Circulation"},{"key":"R2-20250506","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jacc.2009.02.071","article-title":"Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram.","volume":"54","author":"McLeod","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250506","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.amjcard.2005.03.058","article-title":"Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy.","volume":"96","author":"Montgomery","year":"2005","journal-title":"Am J Cardiol"},{"key":"R4-20250506","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9149(83)80034-4","article-title":"Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy.","volume":"51","author":"Maron","year":"1983","journal-title":"Am J Cardiol"},{"key":"R5-20250506","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0735-1097(83)80269-1","article-title":"Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study.","volume":"2","author":"Shapiro","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"R6-20250506","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy.","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"R7-20250506","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults echocardiographic analysis of 4111 subjects in the CARDIA Study coronary artery risk development in (Young) adults.","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"R8-20250506","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy.","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"key":"R9-20250506","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamacardio.2019.2861","article-title":"Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids).","volume":"4","author":"Norrish","year":"2019","journal-title":"JAMA Cardiol"},{"key":"R10-20250506","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy.","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"R11-20250506","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC).","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"R12-20250506","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.jacc.2020.08.044","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R13-20250506","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/13696998.2021.1978242","article-title":"Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.","volume":"24","author":"Jain","year":"2021","journal-title":"J Med Econ"},{"key":"R14-20250506","doi-asserted-by":"crossref","first-page":"e102969","DOI":"10.1371\/journal.pone.0102969","article-title":"Female sex is associated with worse prognosis in patients with hypertrophic cardiomyopathy in China.","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"R15-20250506","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s41687-020-00269-8","article-title":"Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life.","volume":"4","author":"Zaiser","year":"2020","journal-title":"J Patient Rep Outcomes"},{"key":"R16-20250506","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.amjcard.2016.02.044","article-title":"Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States.","volume":"117","author":"Maron","year":"2016","journal-title":"Am J Cardiol"},{"key":"R17-20250506","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"key":"R18-20250506","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.","volume":"62","author":"Geisterfer-Lowrance","year":"1990","journal-title":"Cell"},{"key":"R19-20250506","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12574-020-00467-9","article-title":"The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy.","volume":"18","author":"Mande\u015f","year":"2020","journal-title":"J Echocardiogr"},{"key":"R20-20250506","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC state-of-the-art review.","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R21-20250506","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.hrthm.2019.07.019","article-title":"The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy.","volume":"17","author":"Finocchiaro","year":"2020","journal-title":"Heart Rhythm"},{"key":"R22-20250506","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy.","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"key":"R23-20250506","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jamacardio.2015.0354","article-title":"How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice.","volume":"1","author":"Maron","year":"2016","journal-title":"JAMA Cardiol"},{"key":"R24-20250506","doi-asserted-by":"crossref","first-page":"e0273567","DOI":"10.1371\/journal.pone.0273567","article-title":"Symptoms and ECG changes precede sudden cardiac death in hypertrophic cardiomyopathy-A nationwide study among the young in Sweden.","volume":"17","author":"B\u00f6rjesson","year":"2022","journal-title":"PLoS One"},{"key":"R25-20250506","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/eurheartj\/ehi108","article-title":"Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol consensus statement of the study group of sport cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European society of cardiology.","volume":"26","author":"Corrado","year":"2005","journal-title":"Eur Heart J"},{"key":"R26-20250506","first-page":"1801","article-title":"Cardiac symptoms before sudden cardiac death caused by hypertrophic cardiomyopathy: a nationwide study among the young in Denmark.","volume":"18","author":"Lynge","year":"2016","journal-title":"Europace"},{"key":"R27-20250506","first-page":"315","article-title":"Presence of physical symptoms in healthy adolescence found to be associated with female gender, obesity, tachycardia, diastolic hypertension and smoking.","volume":"12","author":"Hickcox","year":"2022","journal-title":"Am J Cardiovasc Dis"},{"key":"R28-20250506","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2217\/fca-2021-0144","article-title":"Early repolarization is independently associated with African-American race, younger age, higher BMI and lower heart rate.","volume":"18","author":"Movahed","year":"2022","journal-title":"Future Cardiol"},{"key":"R29-20250506","first-page":"100","article-title":"Higher heart rate is independently associated with abnormal body mass index in a J shape pattern.","volume":"22","author":"Hickcox","year":"2023","journal-title":"Crit Pathw Cardiol"},{"key":"R30-20250506","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1476-7120-8-54","article-title":"Prevalence of suspected hypertrophic cardiomyopathy or left ventricular hypertrophy based on race and gender in teenagers using screening echocardiography.","volume":"8","author":"Movahed","year":"2010","journal-title":"Cardiovasc Ultrasound"},{"key":"R31-20250506","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1540-8175.2010.01289.x","article-title":"Obesity in adolescence is associated with left ventricular hypertrophy and hypertension.","volume":"28","author":"Movahed","year":"2011","journal-title":"Echocardiogr"},{"key":"R32-20250506","first-page":"e13","article-title":"Prevalence of mitral valve prolapse and associated valvular regurgitations in healthy teenagers undergoing screening echocardiography.","volume":"15","author":"Sattur","year":"2010","journal-title":"Exp Clin Cardiol"},{"key":"R33-20250506","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/HPC.0000000000000168","article-title":"Higher prevalence of abnormal electrocardigrams (ECG) in African Americans undergoing screening ECG and echocardiography.","volume":"18","author":"Movahed","year":"2019","journal-title":"Crit Pathw Cardiol"},{"key":"R34-20250506","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/pace.12913","article-title":"Electrocardiography screening for hypertrophic cardiomyopathy.","volume":"39","author":"Campbell","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"R35-20250506","first-page":"224","article-title":"Identifying hypertrophic cardiomyopathy patients by classifying individual heartbeats from 12-lead ECG signals.","volume":"2014","author":"Rahman","year":"2014","journal-title":"Proceedings (IEEE Int Conf Bioinformatics Biomed)"},{"key":"R36-20250506","doi-asserted-by":"crossref","first-page":"e999","DOI":"10.1542\/peds.2011-0643","article-title":"Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis.","volume":"129","author":"Rodday","year":"2012","journal-title":"Pediatrics"},{"key":"R37-20250506","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41569-020-00445-9","article-title":"Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management.","volume":"18","author":"Krittanawong","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R38-20250506","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41569-020-00503-2","article-title":"Artificial intelligence-enhanced electrocardiography in cardiovascular disease management.","volume":"18","author":"Siontis","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R39-20250506","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R40-20250506","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.104.507723","article-title":"Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.","volume":"112","author":"Rickers","year":"2005","journal-title":"Circulation"},{"key":"R41-20250506","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/hrt.2003.014969","article-title":"Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.","volume":"90","author":"Moon","year":"2004","journal-title":"Heart"},{"key":"R42-20250506","doi-asserted-by":"crossref","first-page":"e006309","DOI":"10.1161\/CIRCIMAGING.117.006309","article-title":"Discrepant measurements of maximal left ventricular wall thickness between cardiac magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathy.","volume":"10","author":"Hindieh","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"R43-20250506","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10554-016-0858-4","article-title":"Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.","volume":"32","author":"Corona-Villalobos","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"R44-20250506","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.amjcard.2016.11.010","article-title":"Comparison of maximal wall thickness in hypertrophic cardiomyopathy differs between magnetic resonance imaging and transthoracic echocardiography.","volume":"119","author":"Bois","year":"2017","journal-title":"Am J Cardiol"},{"key":"R45-20250506","doi-asserted-by":"crossref","first-page":"e005372","DOI":"10.1161\/CIRCIMAGING.116.005372","article-title":"How to image hypertrophic cardiomyopathy.","volume":"10","author":"Maron","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"R46-20250506","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5603\/CJ.a2016.0019","article-title":"Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.","volume":"23","author":"Kamal","year":"2016","journal-title":"Cardiol J"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:01:55Z","timestamp":1746558115000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000346","relation":{},"ISSN":["1535-2811"],"issn-type":[{"type":"electronic","value":"1535-2811"}],"subject":[],"published":{"date-parts":[[2024,1,29]]}}}